Cardiac Biomarker Study

This is a first in human study that evaluates a novel radiotherapy technology called SBRT in the treatment of breast cancer. Elderly women with small breast cancers will have five treatments with SBRT treatments over 2 weeks. They will...

Acupuncture-like Stimulation

Relatives of women with BRCA1 and BRCA2 breast cancer are at increased risk of developing breast cancer. Currently these women are offered genetic testing and counselling. In the UPTAKE study, relatives of women with hereditary breast cancer provided information...

Identifying Risk Factors

Daily breast irradiation for 3 to 4 weeks is standard treatment after lumpectomy for breast cancer. In a pilot study JCC researchers are studying a novel radiation regimen consisting of a daily treatment for only 5 days.

Novel Molecular Breast Imaging Camera

Triple (estrogen receptor, progesterone receptor, HER2) negative breast cancer has a poor prognosis and is associated with the genetic type called basal. In this study gene sequencing was conducted on frozen breast cancer samples from 10 triple negative...

Comprehensive Genomic Characteristics

Comprehensive Genomic Characteristics of Basal-like Breast Cancers Researchers: Co-Principal Investigators: A. Bane & M. Levine Status: Completed Triple negative breast cancer (TNBC) refers to tumuors where the estrogen receptor (ER) and progesterone receptor are negative. In addition, HER2 neu...

Hereditary Breast Cancer BRCA1/BRCA2

(UPTAKE) Understanding predictive testing attitudes in BRCA1/2 Kindreds Researchers: Co-Principal Investigators: K. Bell & L. Learn Co-Investigators: L. Bordeleau, K. Zbuk Status: Completed Hereditary breast cancer accounts for 5-10% of all breast cancer diagnoses and is primarily caused by...

Daily Partial Breast Irradiation

(OPAR) Once-a-day partial breast irradiation: A feasibility study Researchers: Co-Principal Investigators: D. Kim & T. Whelan Co-Investigators: J. Wright, J. Sussman, B. Strang, H. Reiter, S. Voruganti, G. Okawara, I. Dayes, J. Julian Status: Completed BRIGHT provided funding to...